Targeting CD73 in the tumor microenvironment with MEDI9447. - Wikidata - awgldk - TriplyDB

Targeting CD73 in the tumor microenvironment with MEDI9447.

Targeting CD73 in the tumor microenvironment with MEDI9447.

http://www.wikidata.org/entity/Q37224639

about

Head and Neck Carcinoma Immunotherapy: Facts and Hopes.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Targeting adenosine in cancer immunotherapy: a review of recent progress.Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases.Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over.Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.Targeting immunosuppressive adenosine in cancer.Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.Ectonucleotidase inhibitors: a patent review (2011-2016).Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade.CD73 expression and clinical significance in human metastatic melanoma.Targeting adenosine for cancer immunotherapy.Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1

P2860

Q38650710-69DBB0BC-E931-41A3-A702-09821C49093C Q39161005-9BC806B4-AD3C-4972-98E3-6EC2907C1722 Q39235260-0A0979FC-4808-44D5-A17F-C5EF09E0BE3E Q40162722-3BB931C2-1630-4E9D-A604-4CD900C8C847 Q41718154-603C1050-BF89-4759-BAD7-7C9AFCB25CE1 Q42387961-87FFB4B3-8DB1-44D7-A09B-BE75F38F2735 Q46026307-C4BA0D4E-544B-4A4B-BA80-66E6F8B3F79A Q46140918-8AE6EB37-E1A6-43F5-B7FF-790C0D4CFB8F Q49791703-456C22E7-06CF-46C9-AE66-2B9E514FAC69 Q50224587-B8025356-6047-4800-B587-7BF2EF0D0713 Q52323624-443FA1B6-CD9C-493A-A810-F8DE31B26974 Q52365353-BBE3F8C0-E0F7-49FE-877B-4466A08A6DB0 Q52649982-E2059966-5BB0-4446-8A3A-5F1C480A7D10 Q55001315-E4D346F1-14EC-4892-99E7-F28A709C3C00 Q55122005-27F13C2D-6B19-473D-80CE-4F6905B06323 Q55282181-D53AE3FF-9E25-4700-80E8-47417731D70F Q55330380-B3FAAB95-0A09-4D30-8C26-91F6FC2B5565 Q56891008-162C37D1-3494-4864-A0F3-9D27C4F36647 Q58740200-18150B83-FB91-4A58-B661-33F042C0D082

P2860

Targeting CD73 in the tumor microenvironment with MEDI9447.

http://www.wikidata.org/entity/Q37224639

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting CD73 in the tumor microenvironment with MEDI9447.

@en

Targeting CD73 in the tumor microenvironment with MEDI9447.

@nl

type

label

Targeting CD73 in the tumor microenvironment with MEDI9447.

@en

Targeting CD73 in the tumor microenvironment with MEDI9447.

@nl

prefLabel

Targeting CD73 in the tumor microenvironment with MEDI9447.

@en

Targeting CD73 in the tumor microenvironment with MEDI9447.

@nl

P1433

Q37224639-EFE6F151-F76B-4EBE-B73C-04106BE6C96A

P1476

Q37224639-735A786E-96EB-4DBE-9B9C-C75CE301A504

P2093

Q37224639-03CEF060-44AC-405A-856A-52C7E384FCD5

Q37224639-2C5C5BFA-B5F9-43D3-BF63-06B033363C7E

Q37224639-2D5C0546-D9FB-4E09-8627-27F2A903B528

Q37224639-3F962E05-C6F5-4766-8920-00D426A57211

Q37224639-4D1F10FC-D968-4A07-AF5A-E8400C2462E1

Q37224639-55B0294D-FF8F-4A85-AD18-DE1CC73F030A

Q37224639-572B6ED4-2ADD-43C5-BC4D-8E828378F442

Q37224639-579D3A77-BBCF-4AA9-8A79-D74E18E9C4A9

Q37224639-69A08B2D-B716-4018-A7B0-B54F2B8FFFBF

Q37224639-7480D946-ABB4-4A1D-B46F-11D2F802B729

P2860

Q37224639-1012FADB-1E6E-4C19-A804-FBB25E9D786B

Q37224639-1294B50B-3F96-4BCB-A66C-D22003D3A744

Q37224639-12C3AFF2-5A0B-4076-B48C-FD4C7812096D

Q37224639-19AE7E98-BB80-44FA-9296-051E1FA727E3

Q37224639-1E6EA9DC-E5E1-4DF2-B894-AAFDAFC3633B

Q37224639-2363EDA5-BD75-455D-9BD7-4639E4E60977

Q37224639-239B3B0F-9FC1-405E-B383-C1E5F6547434

Q37224639-376EB200-4872-403F-8E53-2FFB3CE3881C

Q37224639-43156D62-3511-4FA2-AF2E-C2302F907FCD

Q37224639-485BC3C0-9511-48C7-B345-AAC739BA4CEB

P304

Q37224639-5BA04AE7-5214-4F86-8507-7D8320A83F14

P31

Q37224639-FC038067-9E0C-45AD-A5AB-35158D67194D

P356

Q37224639-DB68CCA4-A616-4D81-939A-E07A4FE10B11

P433

Q37224639-FE994528-2099-48A5-903B-D706BD0A0252

P478

Q37224639-5A196B78-2D96-4499-AFF6-D4778C425D6B

P577

Q37224639-AFD68501-3995-43B0-B3D5-E68D3E838418

P698

Q37224639-5D9BB5A4-BDB3-408B-9EC8-8E615FF4D058

P932

Q37224639-E8AF78D2-7DAB-4B95-B13D-4E1ED22FD72E

P356

2162402X.2016.1208875

P1433

P1476

Targeting CD73 in the tumor microenvironment with MEDI9447.

@en

P2093

Carl M Hay

http://www.w3.org/2001/XMLSchema#string

Ching Ching Leow

http://www.w3.org/2001/XMLSchema#string

Edmund Poon

http://www.w3.org/2001/XMLSchema#string

Erin Sult

http://www.w3.org/2001/XMLSchema#string

Gundo Diedrich

http://www.w3.org/2001/XMLSchema#string

Jonathan Rios-Doria

http://www.w3.org/2001/XMLSchema#string

Kathy Mulgrew

http://www.w3.org/2001/XMLSchema#string

Kelly A McGlinchey

http://www.w3.org/2001/XMLSchema#string

Kris F Sachsenmeier

http://www.w3.org/2001/XMLSchema#string

Melissa Damschroder

http://www.w3.org/2001/XMLSchema#string

P2860

Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells

Structural characterization of a human Fc fragment engineered for lack of effector functions

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy

T cell signalling through CD73

Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment

Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73)

Affinity maturation of phage display antibody populations using ribosome display.

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.

P304

e1208875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2016.1208875

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27622077

http://www.w3.org/2001/XMLSchema#string

P932

5007986

http://www.w3.org/2001/XMLSchema#string